UniPharma Co., Ltd. (6621) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for UniPharma Co., Ltd. (6621:TWSE), powered by AI.

Current Price
$12.15
Sector
Healthcare
What is the UniPharma Co., Ltd. stock price forecast?

UniPharma Co., Ltd. is currently trading at $12.15. View real-time AI analysis on Alpha Lenz.

What is UniPharma Co., Ltd. insider trading activity?

View the latest insider trading data for UniPharma Co., Ltd. on Alpha Lenz.

What is UniPharma Co., Ltd.'s P/E ratio?

View UniPharma Co., Ltd.'s valuation metrics on Alpha Lenz.

UniPharma Co., Ltd.

TWSE · 6621
NT$12.15+0.40(+3.40%)
Ask about UniPharma Co., Ltd.'s future dividend policy...
Alpha Chat Insight

UniPharma Co., Ltd.'s ROE is -15.8%. Explore profitability and growth together.

Ask for details

Company Overview

UniPharma Co., Ltd. is a diversified healthcare company specializing in the distribution of pharmaceutical drugs, medical devices, and diagnostic reagents across Taiwan. Incorporated in 1998 and headquartered in Taipei, UniPharma caters to a broad spectrum of medical professionals by supplying diagnostic tests and therapeutic products in fields such as oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. Its offerings include in-vitro diagnostic tests, various injectable medications—such as morphine analgesics and antidotes for drug overdoses—and specialized equipment for cancer treatment and medical procedures. UniPharma’s clientele encompasses medical centers, regional hospitals, and clinics, reflecting its important role as an intermediary in Taiwan’s healthcare supply chain. The company also engages in drug research and development, clinical trials, and marketing services, contributing to advancements within the nation’s medical technology and specialty drug sectors. Through its comprehensive distribution network and support for innovation, UniPharma occupies a notable position in the regional healthcare market, directly impacting the accessibility and quality of medical supplies and pharmaceuticals available throughout Taiwan.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees31

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$88.44MRevenue
0.00Shares Out
31Employees

Margins

53.39%Gross
-37.82%EBITDA
-49.89%Operating
-45.84%Pre-Tax
-45.84%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-11.62%Rev 3Yr
-8.60%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-13.43%ROA
-15.76%ROE
-13.39%ROIC

Financial Health

NT$29.00MCash & Cash Equivalents
NT$16.20MNet Debt
19.67%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

UniPharma Co., Ltd. (ticker: 6621) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 31 employees.

The current price is 12.15 with a P/E ratio of -x and P/B of -x.

ROE is -15.76% and operating margin is -49.89%. Annual revenue is $88M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
UniPharma Co., Ltd. (6621) Stock Forecast 2026 $12.15 — Price, Financials & Analyst Targets | Alpha Lenz